Sale!

CDC73 Gene Hyperparathyroidism Type 2 Familial Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CDC73 gene hyperparathyroidism type 2 familial genetic test is a specialized diagnostic procedure designed to identify mutations in the CDC73 gene, which are associated with the development of familial isolated hyperparathyroidism type 2 (FIHP2). This condition is characterized by the overproduction of parathyroid hormone, leading to elevated calcium levels in the blood and various health issues, including kidney stones, osteoporosis, and severe bone pain.

Conducted at DNA Labs UAE, this genetic test is crucial for individuals with a family history of hyperparathyroidism, as it helps in early detection and management of the condition. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific mutations in the CDC73 gene.

The cost of the CDC73 gene hyperparathyroidism type 2 familial genetic test is 4400 AED. The price reflects the comprehensive analysis and the specialized expertise required to interpret the results accurately. By identifying individuals at risk, this test enables targeted monitoring and timely intervention, potentially preventing the severe complications associated with hyperparathyroidism.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDC73 Gene Hyperparathyroidism Type 2 Familial Genetic Test

At DNA Labs UAE, we offer the CDC73 Gene Hyperparathyroidism Type 2 Familial Genetic Test to help diagnose and screen for this genetic condition. The test is priced at 4400.0 AED and requires a blood sample, extracted DNA, or one drop of blood on an FTA card. The report will be delivered within 3 to 4 weeks using NGS technology.

Test Details

The CDC73 gene is associated with a condition called Hyperparathyroidism Type 2, Familial (HPT2). This condition is characterized by the development of multiple tumors in the parathyroid glands, leading to excessive production of parathyroid hormone (PTH) and increased levels of calcium in the blood (hypercalcemia).

NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of HPT2, NGS testing can identify mutations or changes in the CDC73 gene associated with this condition.

NGS testing for HPT2 is beneficial for the diagnosis of affected individuals and genetic screening in at-risk individuals, such as family members of those affected by HPT2. Early detection and management of the condition, including regular monitoring of calcium levels and potential surgical intervention, can be achieved by identifying individuals with CDC73 gene mutations.

It is crucial to note that genetic testing for HPT2 should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors. These professionals can provide appropriate counseling and guidance based on the test results.

Test Components

  • Test Name: CDC73 Gene Hyperparathyroidism Type 2 Familial Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hepatology Nephrology Endocrinology Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CDC73 Gene Hyperparathyroidism Type 2 Familial NGS Genetic DNA Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by CDC73 Gene Hyperparathyroidism Type 2 Familial NGS Genetic DNA Test gene CDC73.

Test Name CDC73 Gene Hyperparathyroidism type 2 familial Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CDC73 Gene Hyperparathyroidism type 2, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDC73 Gene Hyperparathyroidism type 2, familial NGS Genetic DNA Test gene CDC73
Test Details

The CDC73 gene is associated with a condition called Hyperparathyroidism Type 2, Familial (HPT2). This condition is characterized by the development of multiple tumors in the parathyroid glands, which leads to excessive production of parathyroid hormone (PTH) and increased levels of calcium in the blood (hypercalcemia).

NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of HPT2, NGS testing can be used to identify mutations or changes in the CDC73 gene that are associated with the development of this condition.

NGS testing for HPT2 can help in the diagnosis of affected individuals and can also be used for genetic screening in at-risk individuals, such as family members of those affected by HPT2. Identifying individuals with mutations in the CDC73 gene can allow for early detection and management of the condition, including regular monitoring of calcium levels and potential surgical intervention to remove the affected parathyroid glands.

It is important to note that genetic testing for HPT2 should be performed and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the test results.